CureApp Institute

Dr. Kohta Satake is clinical physician specialized in respiratory medicine and smoking cessation, co-founder and CEO of CureApp Inc, and a co-founding director of CureApp Institute. Having graduated and obtained Bachelor of Medicine from the Keio University School of Medicine, Japan in 2007, he completed residency in Japanese Red Cross Kitami Hospital, Hokkaido, Japan and a fellow in Pulmonology at Japanese Red Cross Society Medical Center, Tokyo, Japan. In 2012, he went off to study abroad at overseas graduate schools gaining global experience and in China and the United States. He completed his Masters of Business Administration (MBA) from the China Europe International Business School (CEIBS), Shanghai, China, as well as his Masters of Public Health (MPH) from the John Hopkins Bloomberg School of Public Health, Baltimore, USA. At Johns Hopkins, he has been engaged in biomedical informatics research, especially in digital therapeutics and its cost-effectiveness analysis. After returning back to Japan in 2014, he started CureApp Inc, Tokyo, Japan, No.1 digital therapeutics company in Japan.

Dr. Akihiro Nomura is a clinical cardiologist, a translational research scientist, and a co-founding director of CureApp Institute. He received his MD from Kanazawa University, Japan, having completed residency in Internal Medicine at St. Luke’s International Hospital, Tokyo, Japan and a fellow in Cardiology at Kokura Memorial Hospital, Kitakyusyu, Japan. Then He obtained his PhD at Kanazawa University Graduate School of Medicine. During his PhD course, he also received research training in cardiovascular genetics using high throughput sequencing and bioinformatics in the Kathiresan lab under Principal Investigator Sekar Kathiresan, MD at the Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, USA for more than two years. His research focus is to apply groundbreaking biomedical technologies.